Michael Eaddy

2.0k total citations
96 papers, 1.5k citations indexed

About

Michael Eaddy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Michael Eaddy has authored 96 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 15 papers in Economics and Econometrics. Recurrent topics in Michael Eaddy's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Urinary Bladder and Prostate Research (10 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Michael Eaddy is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Urinary Bladder and Prostate Research (10 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Michael Eaddy collaborates with scholars based in United States, United Kingdom and Germany. Michael Eaddy's co-authors include C. Ron Cantrell, Manan Shah, Amy Grogg, Steven Burch, Christopher L. Cook, Michael C. Sokol, Julie Locklear, Libby Black, Michael J. Naslund and Augustina Ogbonnaya and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Michael Eaddy

90 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Eaddy United States 21 307 257 234 217 203 96 1.5k
Anuja Roy United States 11 359 1.2× 344 1.3× 150 0.6× 823 3.8× 210 1.0× 41 2.2k
Maurizio Belfiglio Italy 23 344 1.1× 90 0.4× 316 1.4× 33 0.2× 275 1.4× 48 2.0k
Manan Shah United States 20 186 0.6× 87 0.3× 575 2.5× 66 0.3× 97 0.5× 78 1.7k
Tatiana Dilla Spain 20 170 0.6× 246 1.0× 74 0.3× 260 1.2× 76 0.4× 74 1.5k
Michele Sacco Italy 26 362 1.2× 74 0.3× 159 0.7× 37 0.2× 146 0.7× 80 2.8k
DOUGLAS E. MAGER United States 16 225 0.7× 86 0.3× 951 4.1× 57 0.3× 115 0.6× 34 2.0k
Umberto Valentini Italy 26 354 1.2× 85 0.3× 337 1.4× 35 0.2× 130 0.6× 53 2.6k
Jasmina Ivanova United States 19 169 0.6× 104 0.4× 482 2.1× 74 0.3× 78 0.4× 83 1.3k
Julie Birt United States 22 214 0.7× 226 0.9× 46 0.2× 46 0.2× 40 0.2× 61 1.2k
Kathleen A. Foley United States 15 174 0.6× 165 0.6× 140 0.6× 31 0.1× 161 0.8× 33 969

Countries citing papers authored by Michael Eaddy

Since Specialization
Citations

This map shows the geographic impact of Michael Eaddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Eaddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Eaddy more than expected).

Fields of papers citing papers by Michael Eaddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Eaddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Eaddy. The network helps show where Michael Eaddy may publish in the future.

Co-authorship network of co-authors of Michael Eaddy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Eaddy. A scholar is included among the top collaborators of Michael Eaddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Eaddy. Michael Eaddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Humphries, Thomas J., Augustina Ogbonnaya, Michael Eaddy, et al.. (2018). Cardiovascular comorbidities in a United States patient population with hemophilia A: A comprehensive chart review. Advances in Medical Sciences. 63(2). 329–333. 10 indexed citations
2.
Bell, Jill A., Aaron Galaznik, Marlo Blazer, et al.. (2018). Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States. PharmacoEconomics - Open. 3(2). 237–245. 14 indexed citations
5.
Williamson, Todd, et al.. (2017). Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea.. PubMed. 10(3). 113–119. 11 indexed citations
6.
Cairo, Mitchell S., Stephen Thompson, Krishna Tangirala, & Michael Eaddy. (2016). A Clinical and Economic Comparison of Rasburicase and Allopurinol in the Treatment of Patients With Clinical or Laboratory Tumor Lysis Syndrome. Clinical Lymphoma Myeloma & Leukemia. 17(3). 173–178. 18 indexed citations
7.
Seal, Brian, Sean D. Sullivan, Scott D. Ramsey, et al.. (2015). Evaluating Treatments and Corresponding Costs of Prostate Cancer Patients Treated within an Inpatient or Hospital-Based Outpatient Setting. Future Oncology. 11(3). 439–447. 3 indexed citations
9.
Seal, Brian, Sean D. Sullivan, Scott D. Ramsey, et al.. (2014). Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases. Applied Health Economics and Health Policy. 12(5). 547–557. 15 indexed citations
10.
O’Donnell, Thomas F., et al.. (2014). Assessment of thrombotic adverse events and treatment patterns associated with varicose vein treatment. Journal of Vascular Surgery Venous and Lymphatic Disorders. 3(1). 27–34. 30 indexed citations
11.
Stafkey-Mailey, Dana, Pamela Landsman‐Blumberg, Eileen Farrelly, & Michael Eaddy. (2013). Comparison of Methods to Identify Stage IIIB or IV Metastatic Lung Cancer Patients from Electronic Medical Records. Value in Health. 16(7). A582–A582. 1 indexed citations
13.
Eaddy, Michael, et al.. (2012). Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome. Applied Health Economics and Health Policy. 10(6). 431–440. 4 indexed citations
14.
Eaddy, Michael, et al.. (2012). How patient cost-sharing trends affect adherence and outcomes: a literature review.. PubMed. 37(1). 45–55. 198 indexed citations
15.
Crawford, E. David, et al.. (2010). A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer. Prostate Cancer and Prostatic Diseases. 13(2). 162–167. 47 indexed citations
16.
Hensle, Terry W., Amy Grogg, & Michael Eaddy. (2007). Pediatric vesicoureteral reflux: treatment patterns and outcomes. Nature Clinical Practice Urology. 4(9). 462–463. 12 indexed citations
17.
Naslund, Michael J., et al.. (2006). Clinical and economic outcomes in patients treated for enlarged prostate.. PubMed. 12(4 Suppl). S111–6. 19 indexed citations
18.
Hensle, Terry W., Grace Hyun, Amy Grogg, & Michael Eaddy. (2006). 761: Examining Pediatric Vesicoureteral Reflux: a Real-World Evaluation of Treatment Patterns and Outcomes. The Journal of Urology. 175(4S). 247–248. 1 indexed citations
20.
Eaddy, Michael, Amy Grogg, & Julie Locklear. (2005). Assessment of compliance with antipsychotic treatmentand resource utilization in a medicaid population. Clinical Therapeutics. 27(2). 263–272. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026